The Sickle Cell Disease Association of America Inc., a national nonprofit membership organization that advocates for people affected by sickle cell disease, named new board officers: Dr. Edward Donnell Ivy as chief medical officer, Dr. Crawford Strunk as vice chief medical officer and Adeyinka O. Ogunlegan as secretary.
Dr. Edward Donnell Ivy (left) is director of outreach and education at The Possibilities Clinic in Toronto, Ontario, Canada. He was a medical officer at the Health Resources and Services Administration and served the National Institutes of Health in Washington, D.C., where he worked on sickle cell clinical practice guidelines and on projects involving cardiovascular disease and diabetes. As someone living with sickle cell disease, Ivy has made it his life’s work to ensure patients have access to the resources they need.
Dr. Crawford Strunk (center) is a pediatric hematologist with experience and expertise in sickle cell care. He serves on the Sickle Cell Disease Association of America Inc.’s Medical and Research Advisory Committee. Strunk is a staff physician and co-director of the Lifespan Sickle Cell Program at the Cleveland Clinic. He directed the pediatric sickle cell center and co-directed the adult sickle cell center at Toledo Children’s Hospital. He earned his doctorate at the State University of New York Upstate Medical University and graduated from Colby College.
Adeyinka O. Ogunlegan (right) serves as vice president of government affairs and policy at EducationSuperHighway, a national nonprofit organization with the mission to close the broadband internet affordability gap. She served as chair of the Prince George’s Chamber of Commerce’s Legislative Action Committee as well as board president of The Arc Prince George’s County. Among her honors, Ogunlegan received The Maryland Daily Record’s VIP List and Leading Women awards and was recognized as a Prince George’s County Forty Under 40 honoree. She earned a law degree from Howard University and a bachelor’s degree from Georgetown University.